Regulatory Considerations And International Harmonization: Clinical Trials Essay

Length: 3 pages Sources: 2 Subject: Medicine Type: Essay Paper: #6052018 Related Topics: Medical Terminology, Biotechnology, Biomedical, Medicine
Excerpt from Essay :

Clinical Trials: Regulatory Considerations and International Harmonization

Clinical trials are experiments that are carried out in clinical research. They are designed to provide knowledge on detection, prevention, and treatment of diseases as well as other biomedical interventions and new treatment discoveries. One important aspect of clinical trials is the generation of data on safety and efficacy, which require that sponsors get the approval of regulatory bodies and ethnic committees in every country they operate in. However, sometimes, language and culture dissimilarities present challenges that inhibit their effectiveness in foreign territories. This text takes a look at bridging studies and harmonization technologies which are used to reduce the adverse effects that may be brought about by globalization.

Discussion 1: Bridging Studies

Do you think that bridging studies should be required for the development of drugs that companies plan to market in other cultures?

Drug manufacturers today rely on the globalization of pharmaceutical products for their success, but sometimes, sponsors face challenges because populations in different regions differ due to ethnic factors. In such instances, bridging studies are used....

...

A bridging study is the additional study in a new region to bridge the gaps that may arise in clinical data due to dose response, safety, and efficacy. In light of the ethnic sensitivity a newly developed drug poses in different regions, bridging studies should be carried out for all the drugs that are to be marketed in other cultures.

Bridging studies are important because when ethnic dissimilarities are evident, but extrinsic factors like the design, medical practice and the conduct of clinical trials are similar, they provide assurance that the safety, efficacy and doses that come from the original region are applicable in the new region (National Center for Biotechnology Information, 2015). Before, sponsors often had to duplicate majority of foreign clinical data in adherence to regulatory requirements in new territories. Bridging studies reduce this duplication by applying one main clinical data package and only conducting the necessary additional tests that are required to confirm safety and efficacy. Moreover, when properly executed, bridging studies lead to discoveries that will be useful in future research and development efforts.

Discussion 2: Harmonization of Technology

Why is the effort to standardize the language used in reporting clinical trials (MedDRA) important to harmonization throughout the world?

The Medical Dictionary for Regulatory Activities (MedDRA) is a highly specific medical terminology dictionary and thesaurus that is used to facilitate the sharing of regulatory information regarding medical products. It was developed by the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH), and it is used in the documentation, registration, and safe monitoring of pre-marketing and post marketing activities (MedDRA, 2013).

MedDRA is important because it enables drug and device companies to analyze medical history and adverse effects. It makes it easier for practitioners to interpret…

Sources Used in Documents:

References

The Medical Dictionary for Regulatory Activities, MedDRA (2013). Understanding MedDRA: The Medical Dictionary for Regulatory Activities. Retrieved 25 March 2015 from https://www.meddra.org/sites/default/files/main_page_slideshow/meddra2013.pdf

The National Center for Biotechnology Information (2015). Bridging Studies in Clinical Development. U.S. National Library of Medicine. Retrieved 27 March 2015 from http://www.ncbi.nlm.nih.gov/pubmed/12448577


Cite this Document:

"Regulatory Considerations And International Harmonization Clinical Trials" (2015, March 31) Retrieved January 27, 2022, from
https://www.paperdue.com/essay/regulatory-considerations-and-international-2149170

"Regulatory Considerations And International Harmonization Clinical Trials" 31 March 2015. Web.27 January. 2022. <
https://www.paperdue.com/essay/regulatory-considerations-and-international-2149170>

"Regulatory Considerations And International Harmonization Clinical Trials", 31 March 2015, Accessed.27 January. 2022,
https://www.paperdue.com/essay/regulatory-considerations-and-international-2149170

Related Documents
Abuse and Pregnant Women
Words: 13948 Length: 40 Pages Topic: Sports - Women Paper #: 87847047

Violence against pregnant women is a commonplace phenomenon and this research paper will explain the background of violence against pregnant women. Women undergo different forms of violence for instance, beating, threats, raping and unwilling prostitution. Some years back, it wasn't a big issue as approach towards women was a tad bit different back then. Men were treated as the dominant sex due to their physical strength. So is the case

Japanese-American Biopharmaceutical Industry in the 21st Century
Words: 20340 Length: 60 Pages Topic: Medicine Paper #: 56745338

Japanese-American Biopharmaceutical Industry in the 21st Century Optimizing Ethical Drug Availability Between These Two Pharmaceutical Superpowers" The Japanese-American biopharmaceutical industry represents an ongoing international effort between the two top pharmaceutical markets in the world. These two economic powers provide consumers with a majority share of all pharmaceuticals produced in the world. However, a number of pharmaceutical products that are currently available to U.S. residents are unavailable to Japanese consumers. From a humanitarian perspective, this